Navigation Links
Harrisvaccines Awarded Vaccine Product Licensure
Date:9/20/2012

AMES, Iowa, Sept. 20, 2012 /PRNewswire/ -- Harrisvaccines announces United States Department of Agriculture (USDA) licensure of the company's swine flu vaccine, approved by the Department's Center for Veterinary Biologics (CVB) for disease caused by swine influenza virus (SIV) H3N2.

The vaccine is the first to be licensed by the USDA CVB that utilizes RNA Particle Technology. Dr. Kurt Kamrud, Vice President of Research and Chief Scientific Officer at Harrisvaccines, led the company's development and application of RNA Particle Technology - with the ultimate goal of producing a swine influenza vaccine that could be manufactured faster and safer than those produced using modified live or inactivated/killed virus technologies.

This groundbreaking platform allows for the manufacture of vaccines without ever isolating a live virus from infected animals. Only a gene from an infected animal is required to prepare vaccines in as little as four weeks.  The vaccine, licensed as Swine Influenza Vaccine, RNA, Product Code 19A5.D0, was initially submitted to USDA CVB for licensing in 2009.

"When we submitted our license application in 2009, the USDA didn't have an established category into which the product fit," said Jodi French, USDA Liaison at Harrisvaccines.  "There were additional regulatory hoops to jump through in order to achieve this first license."

In addition to USDA licensure of the vaccine, Harrisvaccines received a United States Veterinary Biologics Establishment License, #592, which approves the Ames-based facility for future manufacture of new vaccines for a broader spectrum of veterinary applications, from swine and cattle to companion animal and farmed aquaculture. 

"We were founded in 2006, so this has been a long, challenging road to licensure for a novel technology to be used in animal health," Harrisvaccines founder and President Dr. D.L. "Hank" Harris said. "These USDA licenses mark a major milestone, and perhaps most importantly, signal that this technology is a key fixture in our country's continuing fight against biological threats and ever-changing pathogens."

"With USDA licensure of both the SIV H3N2 vaccine and our Ames manufacturing facility, we expect additional licenses for vaccines manufactured using RNA Particle Technology to be issued on more condensed timelines. With new strains of this virus identified as recently as July of this year, we're particularly interested in our potential to manufacture custom, farm-specific vaccines in a matter of weeks instead of months," Harris said.

About Harrisvaccines

Headquartered in Ames, Iowa, Harrisvaccines focuses on improving animal health and enhancing productivity in the swine, cattle, equine and farmed shrimp industries. Harrisvaccines employs two unique RNA platforms to develop custom farm-specific vaccine products against animal diseases. For more information, visit www.harrisvaccines.com.


'/>"/>
SOURCE Harrisvaccines
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Healionics Awarded $900k Grant from NIH
2. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
3. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
4. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
5. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
6. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
7. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
8. Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device
9. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
10. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
11. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... -- Walgreens has committed to provide drug disposal kiosks ... D.C. as part of a program to combat ... advocacy organization As You Sow. Conrad MacKerron , ... on to unneeded drugs because they lack easily accessible collection ... --> Conrad MacKerron , Senior Vice President at As ...
(Date:2/11/2016)... Ga. , Feb. 11, 2016  MiMedx Group, ... company utilizing human amniotic membrane and other birth tissues, ... platforms to develop and market advanced products and therapies, ... Capital Markets, 2016 Global Healthcare Conference in ... Chairman and CEO, Michael J. Senken , Chief ...
(Date:2/11/2016)... de 2016  A Proliant Biologicals anuncia, com ... bovina (BSA -- Bovine Serum Albumin ) ... Norte da Nova Zelândia, em Feilding. ... da Proliant nos EUA, localizada em ... dos equipamentos foram feitos de forma a reproduzir ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 11, 2016 , ... Florida Hospital presents ... take on the St. Louis Blues at the Amalie Arena. The puck drops at ... walk-through heart exhibit, the MEGA Heart, prior to the game. The MEGA Heart will ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... reverse diabetes has been gearing up for their simultaneous grand openings in March. ... about right now that you’re probably wondering, is reversing diabetes possible? According to ...
(Date:2/11/2016)... ... February 11, 2016 , ... veEDIS Clinical Systems, LLC, ... highly adaptable algorithms, has been updated to help Emergency Department physicians and nurses ... with Zikas and a travel history to affected regions, or potential exposure through ...
(Date:2/11/2016)... FL (PRWEB) , ... February 11, 2016 , ... ... the commencement of a master charity program created to assist the people of ... days, working closely with nonprofit organizations and community leaders. Their hope is to ...
(Date:2/11/2016)... ... ... Dickinson Insurance & Financial Services continues their commitment to act as Agents ... local boy named Barrett, who has been fighting ALL leukemia for almost two years. ... all local families dealing with childhood cancer. Information on how to help is now ...
Breaking Medicine News(10 mins):